Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Essential Hypertension”

82 trials

Showing 20 of 82 results

Large-scale testing (Phase 3)Study completedNCT02206659
What this trial is testing

Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 20
Large-scale testing (Phase 3)UnknownNCT01956786
What this trial is testing

Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

Who this might be right for
Essential Hypertension
Shenzhen Ausa Pharmed Co.,Ltd 540
Large-scale testing (Phase 3)Study completedNCT01001572
What this trial is testing

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Novartis 932
Post-approval studies (Phase 4)Study completedNCT00328965
What this trial is testing

Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea

Who this might be right for
Diabetes Mellitus, Type 2Essential Hypertension
GlaxoSmithKline
Post-approval studies (Phase 4)Study completedNCT00698646
What this trial is testing

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

Who this might be right for
Hypertension
Novartis Pharmaceuticals 384
Large-scale testing (Phase 3)WithdrawnNCT02969265
What this trial is testing

An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension

Who this might be right for
Hypertension
Takeda
Large-scale testing (Phase 3)Study completedNCT00250562
What this trial is testing

A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

Who this might be right for
Hypertension
Novartis 1,171
Post-approval studies (Phase 4)Study completedNCT00130156
What this trial is testing

Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension

Who this might be right for
High Blood Pressure
Eisai Inc. 93
Post-approval studies (Phase 4)Study completedNCT02031861
What this trial is testing

Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shanghai Shyndec Pharmaceutical Co., Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT00950066
What this trial is testing

Irbesartan and Amlodipine Combination in Controlling Blood Pressure

Who this might be right for
Hypertension
Sanofi 270
Not applicableStudy completedNCT00638911
What this trial is testing

Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 33,247
Large-scale testing (Phase 3)Study completedNCT01631227
What this trial is testing

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

Who this might be right for
Essential Hypertension
Abbott 665
Testing effectiveness (Phase 2)Study completedNCT00709930
What this trial is testing

Efficacy and Safety of Weak Extremely Low Frequency Electromagnetic Fields in Mild and Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Kyoto University 20
Testing effectiveness (Phase 2)Study completedNCT03756103
What this trial is testing

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Who this might be right for
Hypertension,Essential
Shanghai Pharmaceuticals Holding Co., Ltd 120
Large-scale testing (Phase 3)Study completedNCT05359068
What this trial is testing

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shanghai Pharmaceuticals Holding Co., Ltd 957
Large-scale testing (Phase 3)Study completedNCT02466490
What this trial is testing

Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension

Who this might be right for
Hypertension, Essential
Stendhal Americas, S.A. 272
Large-scale testing (Phase 3)Study completedNCT00857285
What this trial is testing

Olmesartan Medoxomil Versus Losartan in Patients With Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 130
Testing effectiveness (Phase 2)Study completedNCT00922441
What this trial is testing

A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 92
Large-scale testing (Phase 3)UnknownNCT06141200
What this trial is testing

NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial

Who this might be right for
Essential Hypertension
Natural Wellness Egypt 286
Not applicableStudy completedNCT02336607
What this trial is testing

The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.

Who this might be right for
Hypertension
AstraZeneca 529
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation